Retrospective Study of Intracerebral Hemorrhage Patients in Hospital Parc Taulí
- Conditions
- Intracerebral Hemorrhage
- Interventions
- Other: No intervention
- Registration Number
- NCT04877405
- Lead Sponsor
- Universitat Autonoma de Barcelona
- Brief Summary
This is a retrospective observational study to investigate the clinical, analytical and neuroimaging data generated during routine clinical management of intracerebral hemorrhage. The study will review the data from about 500 patients attended during the last ten years in the Neurology Department of Hospital Parc Taulí de Sabadell.
The aim is to measure the size of the lesion in neuroimage (TC and MRI), the edema, the alterations in diffusion weighted images and to correlate this data with clinical parameters and analytical measurements. With this approach investigators plan to investigate the incidence of hematoma growth, the role of perilesional edema and diffusion changes, and the relation between neuroimaging findings and clinical outcome. The study also try to establish significant correlations between clinical and analytical data, the clinical outcome and and the magnitude of changes in neuroimaging.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 137
- Patients who have been attended at the Hospital Parc Taulí for the last 10 years after presenting an intraparenchymal hemorrhage.
- The patients have had to undergo a computed tomography at the admission and a cranial magnetic resonance during the hospitalization in the time course specified in point in the protocol
- The patients must present in their clinical story the analytical determinations detailed in the protocol.
- Intracerebral hemorrhage secondary to head trauma
- Intracerebral hemorrhage secondary to neoplasm
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Intracerebral hemorraghe No intervention Patients that suffered an intracerebral hemorraghe and that have been subjected to CT and MRI scans
- Primary Outcome Measures
Name Time Method Hematoma growth 2 days Difference of hematoma size between CT conducted at admission and MRI conducted during follow up
Correlation between hematoma growth and analytical parameters 2 days Determine the analytical parameters related with hematoma growth
Correlation between clinical parameters and the size of alterations in DWI 2 days Determine the relationship between clinical parameters and the size of alterations in DWI
Alterations in DWI 2 days Size of alterations in diffusion weighted image
Correlation between analytical parameters and the size of alterations in DWI 2 days Determine the relationship between analytical parameters and the size of alterations in DWI
Correlation between hematoma growth and clinical paramenters 2 days Determine the clinical parameters related with hematoma growth
Correlation between perilesional edema size and clinical outcome 1 month Determine the relationship between the size of edema and clinical outcome
Perilesional edema 2 days Size of edema measured in FLAIR sequences
Correlation between clinical parameters and the size of edema measured in FLAIR sequences 2 days Determine the relationship between clinical parameters and the size of edema
Correlation between analytical parameters and the size of edema measured in FLAIR sequences 2 days Determine the relationship between analytical parameters and the size of edema
Correlation between hematoma growth and clinical outcome 1 month Determine the impact of hematoma growth on clinical outcome
Correlation between the clinical parameters and clinical outcome 1 month Determine the relationship between the clinical parametes and clinical outcome
Correlation between the analyticial parameters and clinical outcome 1 month Determine the relationship between the analytical parametes and clinical outcome
Correlation between the size of DWI alterations and clinical outcome 1 month Determine the relationship between the size of DWI alterations and clinical outcome
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Santiago Rojas Codina MD PhD
🇪🇸Cerdanyola del Valles, Barcelona, Spain